Rapid Evacuation and Access of Cerebral Hemorrhage Registry

Starting soon

Conditions studied: Intracerebral Hemorrhage

In brief

The goal of this observational study is to quantify the real-world effect of minimally invasive surgery (MIS) in patients with acute spontaneous supratentorial intracerebral hemorrhage.

Key facts

Study ID

NCT07651631

Run by

Emory University

People needed

2500

Starts

2026-06-01

Expected to finish

2033-06-01

Last updated by the study team

2026-06-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Head CT demonstrating an acute, spontaneous, intracerebral hemorrhage
• Hemorrhage volume ≥ 20 mLs
• Minimally invasive surgical intervention performed within 7 days of hemorrhage

You may not qualify if…

• Ruptured aneurysm, arteriovenous malformation (AVM), vascular anomaly, moyamoya disease, venous sinus thrombosis, mass or tumor, hemorrhagic conversion of an ischemic infarct, recurrence of a recent ICH (<1 year), as diagnosed with radiographic imaging
• Infratentorial intraparenchymal hemorrhage, including midbrain, pontine, or cerebellum
• Initial hospital arrival ≥ 24 hours after the onset of stroke symptoms
• Last known normal is unknown
• Historical Modified Rankin Score > 4
• Known life-expectancy of less than 1 year prior to ICH
• DNR or comfort measures only
• Known pregnancy in female subjects
• Inability or unwillingness of subject or legal guardian/representative to give written informed consent within 7 days of initial hospital arrival
• Inability to meet follow up requiremen

Where it is running

• Grady Memorial Hospital — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.